1
|
Yuan X, Hou M, Wang Y, Zhang S, Li L, Mi Y, Du H, Yu S, Nan Y. Mitofusin-2 gene polymorphisms and metabolic dysfunction associated fatty liver disease: a case-control study in a Chinese population. J Int Med Res 2023; 51:3000605231187953. [PMID: 37522325 PMCID: PMC10392247 DOI: 10.1177/03000605231187953] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/01/2023] Open
Abstract
OBJECTIVES Mitofusion-2 (Mfn2) may have a role in mitochondrial oxidative stress and insulin resistance that can promote the development of metabolic dysfunction associated fatty liver disease (MAFLD). This retrospective and case control study aimed to explore the relationships between common Mfn2 single nucleotide polymorphisms (SNPs) and MAFLD in a northern Han Chinese population. METHODS Six Mfn2 SNPs (rs2336384, rs873458, rs873457, rs4846085, rs2878677, and rs2236057) were genotyped using the ligase detection reaction in 466 MAFLD patients and 423 healthy controls. Genotype and allele frequencies were calculated, along with haplotype analysis and pairwise linkage disequilibrium. RESULTS The genotype distribution of rs2336384, rs2878677, and rs2236057 among the MAFLD patients showed a significantly different pattern from that of healthy controls. The data showed that an increased risk of MAFLD was significantly correlated with patients carrying the GG genotype of rs2336384, CC genotype of rs873457, TT genotype of rs4846085, TT genotype of rs2878677, and the AA genotype of rs2236057. Moreover, The GGCTTA haplotype was found to be adversely linked with MAFLD by haplotype analysis. CONCLUSION The current findings suggest a strong link between certain Mfn2 gene polymorphisms and MAFLD.
Collapse
Affiliation(s)
- Xiwei Yuan
- Department of Traditional and Western Medical Hepatology & Hebei Key Laboratory of Mechanism of Liver Fibrosis in Chronic Liver Disease, Third Hospital of Hebei Medical University, Shijiazhuang, China
| | - Mengmeng Hou
- Department of Traditional and Western Medical Hepatology & Hebei Key Laboratory of Mechanism of Liver Fibrosis in Chronic Liver Disease, Third Hospital of Hebei Medical University, Shijiazhuang, China
| | - Yiqi Wang
- Department of Traditional and Western Medical Hepatology & Hebei Key Laboratory of Mechanism of Liver Fibrosis in Chronic Liver Disease, Third Hospital of Hebei Medical University, Shijiazhuang, China
| | - Siyu Zhang
- Department of Traditional and Western Medical Hepatology & Hebei Key Laboratory of Mechanism of Liver Fibrosis in Chronic Liver Disease, Third Hospital of Hebei Medical University, Shijiazhuang, China
| | - Lu Li
- Department of Traditional and Western Medical Hepatology & Hebei Key Laboratory of Mechanism of Liver Fibrosis in Chronic Liver Disease, Third Hospital of Hebei Medical University, Shijiazhuang, China
| | - Yingjun Mi
- School of Public Health, Hebei Medical University, Shijiazhuang, China
| | - Huijuan Du
- Department of Traditional and Western Medical Hepatology & Hebei Key Laboratory of Mechanism of Liver Fibrosis in Chronic Liver Disease, Third Hospital of Hebei Medical University, Shijiazhuang, China
| | - Songhao Yu
- Department of Traditional and Western Medical Hepatology & Hebei Key Laboratory of Mechanism of Liver Fibrosis in Chronic Liver Disease, Third Hospital of Hebei Medical University, Shijiazhuang, China
| | - Yuemin Nan
- Department of Traditional and Western Medical Hepatology & Hebei Key Laboratory of Mechanism of Liver Fibrosis in Chronic Liver Disease, Third Hospital of Hebei Medical University, Shijiazhuang, China
| |
Collapse
|
2
|
Yan S, Lian XQ, Wang SB, Wang H, Wang LS. Hyperplasia suppressor gene polymorphisms and essential hypertension: a case-control association study in a central Han Chinese population. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY 2020; 13:1886-1896. [PMID: 32782719 PMCID: PMC7414465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 05/01/2020] [Accepted: 06/11/2020] [Indexed: 06/11/2023]
Abstract
BACKGROUND HSG (hyperplasia suppressor gene, also named Mitofusion-2, Mfn-2) gene polymorphisms have been studied as a candidate gene in essential hypertension, but no clear consensus has been reached in the Chinese population. To systematically explore their possible association, a case-control study was conducted in a central Chinese population. METHODS AND RESULTS We recruited 402 EH patients and 267 normotensive (NT) control subjects. A total of 6 tag SNPs of HSG gene were genotyped successfully by TaqMan assay. The results showed that genotype distribution and the allelic frequency of rs873457, rs2236384, rs4846085, and rs1474868 in the EH and NT groups were significantly different (P < 0.05), although those of rs2295281 and rs17037564 were not. rs2336384, rs873457, rs4846085 and rs1474868 were also closely associated with EH under the dominant genetic model (P < 0.05). Gender-based subgroup analyses showed that significant associations between rs873457, rs2336384, rs4846085, and rs1474868 and EH could be found in males, but not in females. Haplotype analysis indicated that the C-G-T-T-T-G haplotype was positively correlated with EH. CONCLUSION Our study suggested that HSG gene polymorphisms were significantly associated with EH in a central Han Chinese population, especially in male subjects.
Collapse
Affiliation(s)
- Shan Yan
- Department of Cardiology, The First Affiliated Hospital of Nanjing Medical UniversityNanjing 210029, Jiangsu Province, China
- Department of Cardiology, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical UniversityHuaian 223300, Jiangsu Province, China
| | - Xiao-Qing Lian
- Department of Cardiology, The First Affiliated Hospital of Nanjing Medical UniversityNanjing 210029, Jiangsu Province, China
| | - Si-Bo Wang
- Department of Cardiology, The First Affiliated Hospital of Nanjing Medical UniversityNanjing 210029, Jiangsu Province, China
| | - Hao Wang
- Department of Cardiology, The First Affiliated Hospital of Nanjing Medical UniversityNanjing 210029, Jiangsu Province, China
| | - Lian-Sheng Wang
- Department of Cardiology, The First Affiliated Hospital of Nanjing Medical UniversityNanjing 210029, Jiangsu Province, China
| |
Collapse
|
3
|
Han J, Liu J, Zhou Q, Nie S, Liu J, Wen S. Single Nucleotide Polymorphisms (SNPs) Genotyping Reveals that Mfn2 Polymorphisms are Associated with Thoracic Aortic Dissection in Han Chinese Population. Med Sci Monit 2019; 25:2419-2428. [PMID: 30940795 PMCID: PMC6459048 DOI: 10.12659/msm.915272] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
BACKGROUND Many studies have shown that hypertension may contribute to thoracic aortic dissection (TAD). Among the factors that modulate hypertension are endoplasmic reticulum stress and vascular smooth muscle cell proliferation which are in turn modulated by mitofusion-2 (Mfn2). Specifically, we determined, in the Han Chinese population, whether single nucleotide polymorphisms (SNPs) of Mfn2 influenced the occurrence of TAD. MATERIAL AND METHODS Six tagging SNPs of Mfn2 (rs2236057, rs3766741, rs2236058, rs17037564, rs2295281, and rs2336384) were genotyped using a TaqMan assay in 200 TAD patients and 451 health individuals from the Han Chinese population. RESULTS Logistic regression analysis indicated CC genotype of rs2295281 was highly linked to an increased risk of TAD (TT+CT versus CC, OR=0.540, 95% CI [0.320-0.911], P=0.021), implying that TT genotype and CT genotype of rs2295281 have a lower risk for TAD. Logistic regression analysis also indicated that rs2236058 was highly linked to the risk of TAD based on recessive genetic model, which indicated that the GG genotype was a protective factor against TAD (GG versus (CG+CC), OR=0.545, 95% CI [0.351-0.845], P=0.007). CG genotype and CC genotype of rs2236058 had a higher risk for TAD. In addition, rs2236058 was linked to the risk of TAD in the recessive genetic and homozygous models in the normotensive subgroup (GG versus (CG+CC), OR=0.298, 95% CI [0.112-0.792], P=0.015; GG versus CC, OR=0.528, 95% CI [0.302-0.925], P=0.026) but not in the hypertension subgroup. CONCLUSIONS Our findings showed that the occurrence of TAD in a Han Chinese population was influenced by Mfn2 polymorphisms.
Collapse
Affiliation(s)
- Jing Han
- Department of Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China (mainland)
| | - Jielin Liu
- Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China (mainland)
| | - Qi Zhou
- Department of Hypertension, Beijing Anzhen Hospital, Capital Medical University, Beijing, China (mainland)
| | - Shaoping Nie
- Department of Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China (mainland)
| | - Jinghua Liu
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China (mainland)
| | - Shaojun Wen
- Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China (mainland)
| |
Collapse
|
4
|
Li C, Sun D, Liu J, Li M, Zhang B, Liu Y, Wang Z, Wen S, Zhou J. A Prediction Model of Essential Hypertension Based on Genetic and Environmental Risk Factors in Northern Han Chinese. Int J Med Sci 2019; 16:793-799. [PMID: 31337952 PMCID: PMC6643104 DOI: 10.7150/ijms.33967] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/11/2019] [Accepted: 04/22/2019] [Indexed: 11/06/2022] Open
Abstract
Background: Essential hypertension (EH) is a chronic disease of universal high prevalence and a well-established independent risk factor for cardiovascular and cerebrovascular events. The regulation of blood pressure is crucial for improving life quality and prognoses in patients with EH. Therefore, it is of important clinical significance to develop prediction models to recognize individuals with high risk for EH. Methods: In total, 965 subjects were recruited. Clinical parameters and genetic information, namely EH related SNPs were collected for each individual. Traditional statistic methods such as t-test, chi-square test and multi-variable logistic regression were applied to analyze baseline information. A machine learning method, mainly support vector machine (SVM), was adopted for the development of the present prediction models for EH. Results: Two models were constructed for prediction of systolic blood pressure (SBP) and diastolic blood pressure (DBP), respectively. The model for SBP consists of 6 environmental factors (age, BMI, waist circumference, exercise [times per week], parental history of hypertension [either or both]) and 1 SNP (rs7305099); model for DBP consists of 6 environmental factors (weight, drinking, exercise [times per week], TG, parental history of hypertension [either and both]) and 3 SNPs (rs5193, rs7305099, rs3889728). AUC are 0.673 and 0.817 for SBP and DBP model, respectively. Conclusions: The present study identified environmental and genetic risk factors for EH in northern Han Chinese population and constructed prediction models for SBP and DBP.
Collapse
Affiliation(s)
- Chuang Li
- Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Herat Lung and Blood Vessel Diseases, Beijing, People's Republic of China.,Beijing Lab for Cardiovascular Precision Medicine, Beijing, People's Republic of China
| | - Dongdong Sun
- Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Herat Lung and Blood Vessel Diseases, Beijing, People's Republic of China.,Beijing Lab for Cardiovascular Precision Medicine, Beijing, People's Republic of China
| | - Jielin Liu
- Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Herat Lung and Blood Vessel Diseases, Beijing, People's Republic of China.,Beijing Lab for Cardiovascular Precision Medicine, Beijing, People's Republic of China
| | - Mei Li
- Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Herat Lung and Blood Vessel Diseases, Beijing, People's Republic of China.,Beijing Lab for Cardiovascular Precision Medicine, Beijing, People's Republic of China
| | - Bei Zhang
- Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Herat Lung and Blood Vessel Diseases, Beijing, People's Republic of China.,Beijing Lab for Cardiovascular Precision Medicine, Beijing, People's Republic of China
| | - Ya Liu
- Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Herat Lung and Blood Vessel Diseases, Beijing, People's Republic of China.,Beijing Lab for Cardiovascular Precision Medicine, Beijing, People's Republic of China
| | - Zuoguang Wang
- Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Herat Lung and Blood Vessel Diseases, Beijing, People's Republic of China.,Beijing Lab for Cardiovascular Precision Medicine, Beijing, People's Republic of China
| | - Shaojun Wen
- Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Herat Lung and Blood Vessel Diseases, Beijing, People's Republic of China.,Beijing Lab for Cardiovascular Precision Medicine, Beijing, People's Republic of China
| | - Jiapeng Zhou
- College of Life Sciences, Hunan Normal University, Changsha, People's Republic of China.,Beijing Mygenostics Co., Ltd., Beijing, People's Republic of China
| |
Collapse
|
5
|
Zhang X, Chen W, Li J, Qi S, Hong S, Wang Y, Gao L, Shi Z, Liu Y, Liu W, Chi Y, Liu C, Fu Y, Yin X. Involvement of mitochondrial fission in calcium sensing receptor-mediated vascular smooth muscle cells proliferation during hypertension. Biochem Biophys Res Commun 2017; 495:454-460. [PMID: 29128361 DOI: 10.1016/j.bbrc.2017.11.048] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2017] [Accepted: 11/07/2017] [Indexed: 10/18/2022]
Abstract
Hyperproliferation of vascular smooth muscle cells (VSMC) is a major risk factor for cardiovascular diseases. Proper mitochondrial fission and fusion is involved with VSMC function. However, the role and mechanism of mitochondrial morphological changes in VSMC proliferation are not well understood. Here, we found that calcium sensing receptor (CaSR) was increased in the aortas from spontaneous hypertensive rats (SHRs) compared with age-matched Wistar Kyoto (WKY) rats. There was also an increase in mitochondrial fission and VSMC proliferation, which was attenuated by Calhex231. In primary rat VMSC, angiotensin II (Ang II) stimulation induced cytosolic [Ca2+]i increase, mitochondrial shortening and proliferation, all of which could be attenuated by pretreatment with mitochondrial division inhibitor-1 (Mdivi-1) and Calhex231. Our data indicate that CaSR-mediated mitochondrial fission could be a therapeutic target for hyperproliferative disorders.
Collapse
Affiliation(s)
- Xin Zhang
- Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, PR China
| | - Wenjia Chen
- Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, PR China
| | - Jiawen Li
- Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, PR China
| | - Shuhan Qi
- Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, PR China
| | - Siting Hong
- Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, PR China
| | - Ying Wang
- Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, PR China
| | - Lei Gao
- Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, PR China
| | - Zhiyu Shi
- Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, PR China
| | - Yue Liu
- Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, PR China
| | - Wenxiu Liu
- Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, PR China
| | - Yinyu Chi
- Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, PR China
| | - Chunnan Liu
- Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, PR China
| | - Yu Fu
- Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, PR China
| | - Xinhua Yin
- Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, PR China.
| |
Collapse
|
6
|
Lian Z, Yang L, Bian Y, Zeng L, Li M, Sun Y, Li W. Effects of Tai chi on adults with essential hypertension in China: A systematic review and meta-analysis. Eur J Integr Med 2017. [DOI: 10.1016/j.eujim.2017.05.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|